Luminex Molecular Diagnostics Inc. has recalled approximately 3,988 units of its NxTAG Respiratory Pathogen Panels, including the version with SARS-CoV-2 testing. These diagnostic kits, used by healthcare facilities to identify respiratory infections, may report an elevated rate of non-specific human Metapneumovirus (hMPV) results. This defect has a 7.6% predicted probability of occurrence, particularly when a clinical sample is already positive for another target, leading to incorrect reports of co-infections. If you have been tested using these specific diagnostic panels between September 2024 and January 2025, you should contact your healthcare provider to discuss your results.
The device may erroneously report a positive result for human Metapneumovirus (hMPV) when the virus is not actually present. This false positive result can lead to unnecessary treatments, incorrect medical management, or a failure to investigate the true cause of a patient's symptoms.
Clinical notification and manufacturer coordination.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.